Search Results 2201-2210 of 12966 for Ibrance
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked ...
— A new multicenter study led by Mayo Clinic researchers has established a practical, evidence-based definition for rapidly progressive dementia (RPD), a rare[.
Mayo Clinic Uncovers a Crucial Tumor Suppression Function of p53, the Most Commonly Mutated Gene in Human Cancers. Robert Nellis. April 24, 2014. Minnesota.
The purpose of this study is to confirm the effectiveness and safety of terlipressin in the treatment of adult patients with hepatorenal syndrome (HRS) type 1.
ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest oncology findings at the 2025 American Society of Clinical ...
Marla Broadfoot, Ph.D. March 29, 2018. Science Saturday: Genetic testing to enhance multiple myeloma treatment featured image.
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
About this study. This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib ...
Health & Wellness ; Cancer Diagnosis: 11 Tips for Coping. Jennifer O'Hara. April 24, 2015 ; MAYO CLINIC RADIO. Dana Sparks. April 23, 2015 ; Heart Surgery Puts ISU ...
At Mayo Clinic, biomedical engineer Benjamin Brinkmann, Ph.D., is developing tools and technologies that help reveal brain patterns — making epileptic seizures ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!